← Back to all signals
RESEARCH PAPER ANALYSIS

Impact of risk and lifestyle factors on therapy goals in the treatment of breast cancer and gynecological cancer patients with integrative medicine.

AI interpretation is pending for this paper.

Open original publication →
PMID40204922
JournalArchives of gynecology and obstetrics
Publication Date2025-04-09
Ingested2026-08-02 12:04 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: As a result of advancements in the diagnosis and therapy of cancer, the prognosis for cancer patients has significantly improved. The benefits of a significantly enhanced survival time lead to a more extensive concern with quality of life and managing the side effects during oncological treatment. Implementing integrative medicine strategies has been found to reduce the side effects of therapy and disease. In 2021 the S3 guideline on complementary medicine in oncology was published for the first time, which takes a stand on the most common aspects of complementary and integrative medicine in Germany. The aim was to see whether a previous healthy life style impacts the success of integrative medicine for patients. METHODS: Within the framework of a cross-sectional study over 15 months, 120 cancer patients were monitored at a standardized integrative medicine consultancy service at the University Integrative Medicine Center of the University Hospital Erlangen, Department of Gynecology and Obstetrics. The basic questionnaire consisted of questions on socioeconomic background information, lifestyle factors, such as dietary habits or smoking behavior, as well as information on the gynecological situation. Furthermore, an evaluation based on patient-reported therapy goals concerning the reduction of side effects of conventional cancer treatments, enhancement of disease-related quality of life and better stress and disease management, active participation in cancer treatments, mind-body stabilization, and improvements in coping strategies were assessed. In addition, the impact of patient characteristics and lifestyle on the subjective achievement of these outcomes was evaluated to set the answers in context and show its influence. Statistical analysis was performed using SPSS Statistics for Windows version 26 (IBM Corporation, Armonk in New York, USA). Mean, standard deviation, minimum, and maximum were calculated for age and BMI. The other characteristics regarding demographics, lifestyle, tumor disease, and therapy were analyzed based on their respective absolute and relative frequencies. RESULTS: A large majority of the patients' participation goal was to reduce cancer-related side effects (90.8%), second were the aspects of "Improvement of the disease-related quality of life "(72.5%). In both cases, this common goal was only fully achieved for about one quarter of the patients (25.7%/24.1%), but partially achieved in more than half of the asked patients (53.2%/52.9%). Half of the patients reported that they achieved active participation in cancer treatment with integrative medicine. Around 50% partially achieved stabilization of the body, soul, and spirit, stress, disease management, improvement in cancer-related quality of life, and reduced the side effects of conventional cancer therapies. The success of integrative therapy was independent of age, BMI, family status, children, level of education, insurance type, alcohol and tobacco consumption, sport, low-fat diet, daily fruit and vegetable servings, interest in diets, and previous use of diets. CONCLUSIONS AND DISCUSSION: Using a standardized procedure in integrative medicine allows patients to receive high-quality care. The previous standard of living has no effect on the benefits of integrative medicine for the patient. The goals through the use of integrative medicine could be achieved by all patient groups. It is highly encouraged to incorporate counseling and evidence-based integrative medicine into the clinical routines of cancer centers and adapt postgraduate medical education. Finally, the evidence base for the recommendations should also be strengthened by further research into the use of integrative medicine.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Nasopharyngeal Branchial Cleft Cyst in an Elderly Man: An Atypical Presentation. Iranian journal of otorhinolaryngology 55.5 2 A Cross-Sectional Study of Women's Cervical Cancer Knowledge and Acceptance of Human Papillomavirus Vaccination in Makeni, Sierra Leone. Journal of health care for the poor and underserved 59.5 3 Correction to: The effect of centralized care on the management of postoperative fluctuations in plasma sodium concentration after pediatric suprasellar brain tumor surgery. Pituitary 47.5 4 Tumor Number and Model for End-Stage Liver Disease Score as Selection Criteria for Resection or Embolization of Intermediate-Stage Hepatocellular Carcinoma. Cancer reports (Hoboken, N.J.) 57.2 5 Engineered flavonoid disrupts mitochondrial AIF/CHCHD4 complex for targeted cancer therapy. Acta pharmaceutica Sinica. B 55.54 6 Clinical Characteristics and Long-Term Follow-Up of Leukoencephalopathy in Pediatric Acute Lymphoblastic Leukemia After Chemotherapy. Cancer management and research 65.84 7 Sex and age at exposure influence 131I biodistribution and dosimetry in Sprague-Dawley rats. Biology of sex differences 62.3 8 Distress Screening and Pediatric Palliative Care Referral: A Retrospective Case-Control Study in Supportive Cancer Care Delivery. Journal of palliative medicine 67.0 9 A qualitative study exploring the pros and cons of universal pediatric palliative care referral at diagnosis for children with cancer - CORRIGENDUM. Palliative & supportive care 47.5 10 Anesthesia in the Ophthalmology Clinic for Infants Younger Than 1 Year Undergoing Retinoblastoma Treatment. Review of 888 Cases. Paediatric anaesthesia 69.74 11 Comprehensive In Vitro Profiling Demonstrates Successful Immune Evasion of Bioengineered Immune-Shielded Heart Valves. Advanced healthcare materials 50.7 12 Comparative Effectiveness of Antibiotic Prophylaxis Regimens in Pediatric Acute Myeloid Leukemia. Pediatric blood & cancer 64.3 13 The Impact of the COVID-19 Pandemic on Childhood Cancer Survival: A Population-Based Assessment of Survival Patterns Between 2015 and 2023 in Germany. Pediatric blood & cancer 69.52 14 A Phase I/II Trial of Anti-CD22/CD19 CAR-T Cell Therapy, CART2219.1, in Adult and Pediatric Relapsed/Refractory B-ALL. Blood cancer discovery 85.96 15 Radiomics and machine learning for differentiating pediatric intramedullary spinal tumors: a pilot study. European radiology experimental 65.0 16 Intracranial germ cell tumors: an underrecognized diagnostic consideration in adults with sellar/suprasellar lesions. Journal of neuro-oncology 65.5 17 Psychosocial interventions for children and adolescents across the cancer care continuum: A systematic review and meta-analysis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 83.5 18 Ovarian Dysfunction After Gonadotoxic Therapy in Childhood Cancer Survivors: A Cross-Sectional Study From a Resource-Limited Setting. Journal of pediatric hematology/oncology 68.34 19 Self-Efficacy and Knowledge in Cardiotoxicity Management Among Pediatric Oncology Nurses: A Cross-Sectional Mediation Analysis. Journal of pediatric hematology/oncology 63.02 20 Derivation of a dose descriptor for the internal exposure to benzene. International journal of hygiene and environmental health 58.62 21 From childhood trauma to adult health: The association between adverse childhood experiences and preventive healthcare screenings. Journal of epidemiology and population health 38.5 22 Pyroptosis-Related Pathways and Their Impact on Immune Microenvironment Remodeling in Pediatric Ovarian and Adnexal Tumors. Experimental cell research 55.3 23 Expanding Horizons in Fertility Preservation: Diverse Populations, Emerging Indications, and Ethical Considerations. Fertility and sterility 62.8 24 Herbal medicine among vulnerable populations in Cameroon: a systematic review and meta-analysis with clinical, mechanistic, and global health perspectives. Journal of ethnopharmacology 74.0 25 Diagnostic accuracy of growth hormone stimulation tests for growth hormone deficiency following radiotherapy involving the hypothalamic-pituitary axis: protocol for a systematic review and planned meta-analysis. BMJ open 84.74 26 Asynchronous bilateral pulmonary pathology: left-sided congenital pulmonary airway malformation with contralateral malignant pleuropulmonary blastoma in an adolescent. BMJ case reports 58.4 27 Hereditary TTP and Hemolytic Anemia in Newborns. Pediatrics 60.9 28 Thymic age and peripheral residence time determine antitumor competence of CD8+ T cells. Proceedings of the National Academy of Sciences of the United States of America 58.4 29 Population Pharmacokinetics of Topical Timolol Maleate Gel in Healthy Volunteers and Infants With Superficial Infantile Hemangioma. CPT: pharmacometrics & systems pharmacology 75.9 30 Global Trends in Sun Safety and Skin Cancer Prevention Education Among Adolescents: A Bibliometric Analysis. Cureus 58.0 31 Development and Validation of an Interpretable Machine Learning Model for Predicting Early Pulmonary Metastasis Risk in Osteosarcoma. Cancer medicine 66.3 32 Financial toxicity among families of children with cancer: a qualitative systematic review and meta-aggregation. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 77.52
PATIENT-FRIENDLY SUMMARY

Impact of risk and lifestyle factors on therapy goals in the treatment of breast cancer and gynecological cancer patients with integrative medicine.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic